My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,038.40 +5.43 (+0.53%)

Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗

Today 11:07 EST

All three of these healthcare giants are leaders in their niches.

Via The Motley Fool

Topics Artificial Intelligence

The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins

Today 10:30 EST

As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin...

Via Finterra

Topics Economy

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

Today 9:54 EST

As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its...

Via Finterra

Topics Artificial Intelligence Bankruptcy Economy

NVO Shares Rise On Strong Kickstart For Wegovy Pill In US: Retail Eyes Up To $110 As ‘Fair Value’ ↗

January 16, 2026

Via Stocktwits

Disc Medicine, Sanofi, Eli Lilly Shares Slip On Reports Of FDA Increasing Review Time For Drugs Granted Priority Review Vouchers ↗

January 15, 2026

Via Stocktwits

Prediction: 2026 Will Be the Year of Eli Lilly ↗

Today 4:30 EST

A catalyst lies just ahead.

Via The Motley Fool

Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗

January 18, 2026

Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets.

Via The Motley Fool

This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗

January 18, 2026

The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it.

Via The Motley Fool

Topics ETFs Economy

Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗

January 17, 2026

The pharmaceutical leader has plenty of cash and is using it effectively.

Via The Motley Fool

Topics Intellectual Property

Why a $6 Million Allocation to Short-Dated Credit Stands Out Right Now ↗

January 17, 2026

The Invesco BulletShares 2026 Corporate Bond ETF targets investment grade U.S. corporate bonds maturing in 2026 with a defined maturity profile.

Via The Motley Fool

Topics Bonds ETFs Regulatory Compliance

This Company Is Doubling Down on AI. Is the Stock a Buy? ↗

January 16, 2026

The pharmaceutical leader continues to grab headlines.

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly: A Strong Player in the Pharmaceutical Arena ↗

January 16, 2026

Join us as we explore Eli Lilly's impressive market position and financial health. Discover why this pharmaceutical giant is capturing investor attention and what the future may hold for its stock.

Via The Motley Fool

The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine

January 16, 2026

In a milestone that many researchers are calling the "biological equivalent of the moon landing," AlphaFold 3 has officially moved structural biology into a new era of predictive precision. Developed...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? ↗

January 16, 2026

The choice isn't that hard.

Via The Motley Fool

The $5.1 Trillion Wave: Why 2026 is Set to Become the Biggest Year for Global M&A

January 16, 2026

As the global economy shakes off the final remnants of the high-interest-rate era, a massive wave of consolidation is sweeping through corporate boardrooms. Analysts have officially adjusted their...

Via MarketMinute

Topics Artificial Intelligence Economy

Nvidia and Eli Lilly Are Partnering on a $1 Billion Lab. Here's What Investors Need to Know. ↗

January 16, 2026

The high-powered duo is teaming up to build and equip a $1 billion research facility in California.

Via The Motley Fool

Topics Artificial Intelligence

Tema ETFs Adds $8 Million to an Industrial Stock Up 63% This Past Year ↗

January 16, 2026

Powell Industries designs and manufactures custom electrical systems for critical infrastructure in heavy industry and utilities worldwide.

Via The Motley Fool

Topics ETFs Regulatory Compliance

Why A 'Solid' First Week For Oral Wegovy Bodes Well For Novo And Lilly ↗

January 16, 2026

Novo Nordisk's oral Wegovy snagged 3,071 prescriptions in its first week on the market, an analyst said Friday.

Via Investor's Business Daily

Eli Lilly Shares Near Highs As Score Flags Momentum Ahead Of Earnings ↗

January 16, 2026

Eli Lilly's stock experiences strong momentum prior to its upcoming earnings report, supported by robust analyst targets and a solid growth narrative, despite recent volatility.

Via Talk Markets

Chips and Checks: AI and Banks Lead Wall Street's Charge ↗

January 16, 2026

Via Chartmill

Topics Artificial Intelligence

3 Unstoppable Stocks to Buy in 2026 and Hold Forever ↗

January 15, 2026

These stocks are leaders in their respective industries, and they have excellent fundamentals.

Via The Motley Fool

Topics Artificial Intelligence Credit Cards

"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape

January 15, 2026

As 2026 begins, the global mergers and acquisitions (M&A) market is witnessing a profound "renaissance," driven by a confluence of stabilizing interest rates, record levels of corporate cash, and a...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

The Great Broadening: Why the S&P 500 Rally Is No Longer Just a Tech Story

January 15, 2026

As we enter the first weeks of 2026, the narrative of a stock market dominated by a handful of tech giants has finally given way to a more balanced and resilient economic landscape. For the first time...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

The Dealmaking Renaissance: Goldman Sachs and Morgan Stanley Signal a 2026 M&A Surge as Fees Skyrocket

January 15, 2026

The "long winter" of corporate dealmaking has officially thawed, giving way to a robust spring of activity that promises to redefine the financial landscape in 2026. As of January 15, 2026, the Fourth...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

The Atomic Revolution: How AlphaFold 3’s Open-Source Pivot Has Redefined Global Drug Discovery in 2026

January 15, 2026

The decision by Google DeepMind and its commercial sister company, Isomorphic Labs, to fully open-source AlphaFold 3 (AF3) has emerged as a watershed moment for the life sciences. As of January 2026,...

Via TokenRing AI

Topics Artificial Intelligence Derivatives Economy

Exploring the top movers within the S&P500 index during today's session. ↗

January 15, 2026

Via Chartmill

The Silicon Laureates: How the 2024 Nobel Prizes Cemented AI as the New Language of Science

January 15, 2026

The announcement of the 2024 Nobel Prizes in Physics and Chemistry sent a shockwave through the global scientific community, signaling a definitive end to the "AI Winter" and the beginning of what...

Via TokenRing AI

Topics Artificial Intelligence

Eli Lilly’s $1.2 Billion Acquisition of Ventyx Biosciences: Bridging the Gap Between Weight Loss and Chronic Inflammation

January 15, 2026

In a bold move to solidify its dominance in the cardiometabolic market, Eli Lilly and Company (NYSE:LLY) announced on January 7, 2026, that it has entered into a definitive agreement to acquire Ventyx...

Via MarketMinute

Topics Intellectual Property

Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers ↗

January 15, 2026

Eli Lilly And Co (NYSE:LLY) and Novo Nordisk (NYSE:NVO), are reportedly being sued in Texas by compounding pharmacy Strive Specialties

Via Benzinga

Topics Lawsuit

Why Eli Lilly (LLY) Stock Is Down Today

January 15, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) delayed its decision on the company's new oral...

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.